首页> 外文期刊>Risk analysis >Life Cycle Risks for Human Health: A Comparison of Petroleum Versus Bio-Based Production of Five Bulk Organic Chemicals
【24h】

Life Cycle Risks for Human Health: A Comparison of Petroleum Versus Bio-Based Production of Five Bulk Organic Chemicals

机译:人类健康的生命周期风险:石油与生物基生产的五种大宗有机化学品的比较

获取原文
获取原文并翻译 | 示例
       

摘要

This article describes the development and application of a generic approach to the comparative assessment of risks related to the production of organic chemicals by petrochemical processes versus white biotechnology. White biotechnology, also referred to as industrial biotechnology, typically uses bio-based feedstocks instead of the fossil raw materials used in the petrochemical sector. The purpose of this study was to investigate whether the production of chemicals by means of white biotechnology has lower conventional risks than their production by petrochemical processes. Conventional risks are the risks of well-established processes, and not those related to genetically modified microorganisms and plants. Our approach combines classical risk assessment methods (largely based on toxicology), as developed by the life cycle assessment (LCA) community, with statistics on technological disasters, accidents, and work-related illnesses. Moreover, it covers the total process chain for both petrochemical and bio-based products from cradle to grave. The approach was applied to five products: the plastics polytrimethylene terephthalate (PTT), polyhydroxyalkanoates (PHA), polyethylene terephthalate (PET), polyethylene (PE), and ethanol. Our results show that the conventional risks related to the white biotechnology products studied are lower than those of the petrochemical products. However, considering the uncertainties with respect to the ranges of input data, the (incomplete) coverage of emissions by the environmental priority strategies (EPS) 2000 method, and the uncertainties of the assumptions made in this study (i.e., large to very large), the differences in results between bio-based and petrochemical products fall into the uncertainty range. Because of this, future research is necessary to decrease the uncertainties before we can conclude that the conventional risks of biotechnologically produced chemicals are lower than those of fossil-fuel-derived chemicals.
机译:本文介绍了一种通用方法的开发和应用,该方法用于与石化工艺和白色生物技术进行有机化学生产相关风险的比较评估。白色生物技术,也称为工业生物技术,通常使用生物基原料代替石化行业中使用的化石原料。这项研究的目的是调查通过白色生物技术生产的化学品是否比通过石化工艺生产的化学品具有更低的常规风险。常规风险是成熟过程的风险,而不是与转基因微生物和植物有关的风险。我们的方法将生命周期评估(LCA)社区开发的经典风险评估方法(主要基于毒理学)与技术灾难,事故和与工作有关的疾病的统计数据结合在一起。此外,它涵盖了从摇篮到坟墓的整个石化和生物基产品的整个过程链。该方法已应用于五种产品:塑料聚对苯二甲酸丙二醇酯(PTT),聚羟基链烷酸酯(PHA),聚对苯二甲酸乙二醇酯(PET),聚乙烯(PE)和乙醇。我们的结果表明,与研究的白色生物技术产品相关的常规风险低于石化产品。但是,考虑到输入数据范围的不确定性,环境优先策略(EPS)2000方法对排放量的(不完全)覆盖范围以及本研究所做假设的不确定性(即,从大到大) ,生物基产品和石化产品之间的结果差异落在不确定性范围内。因此,有必要进行进一步的研究以减少不确定性,然后我们才能得出结论,生物技术生产的化学品的常规风险低于化石燃料衍生的化学品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号